Announcements

Mission success: Ritonavir crystallization experiments conducted in space worked flawlessly

WEST LAFAYETTE, Ind., March 22, 2024 /PRNewswire-PRWeb/ -- Improved Pharma and Varda Space Industries have published the first mission results in ChemRxiv in an article entitled Return of the Ritonavir: A Study on the Stability of Pharmaceuticals Processed in Orbit and Returned to Earth. The team reports that the most stable form of ritonavir (Form II) Read more

Mission success: Ritonavir crystallization experiments conducted in space worked flawlessly2024-03-25T17:31:07+00:00

Improved Pharma analyzing pharmaceuticals crystallized in space

WEST LAFAYETTE, Ind., Feb. 26, 2024 /PRNewswire-PRWeb/ -- Varda's/close partner's satellite "W-1" was launched into space to demonstrate Varda's spacecraft & reentry capabilities and pharmaceutical hardware functionality, paving the way for microgravity-enabled drug development. While in low earth orbit, melt/cool experiments were successfully conducted on ritonavir. Varda's capsule successfully touched down in the Utah Desert Read more

Improved Pharma analyzing pharmaceuticals crystallized in space2024-02-26T16:39:26+00:00

Improved Pharma Brings Onboard Micro-DSC Hot-Stage System with Imaging Capabilities for Obtaining Thermal Properties of Micro-Quantities of Materials

WEST LAFAYETTE, Ind., Feb. 12, 2024 /PRNewswire-PRWeb/ -- Improved Pharma is pleased to announce expanded capabilities in collaboration with Chemical Microscopy for evaluating the thermal properties of micro-quantities of materials. The newly-added Mettler-Toledo HS84/HS1 DSC controller micro-DSC system is the only true DSC hot stage on the market, and will allow visual observation of thermal events when only Read more

Improved Pharma Brings Onboard Micro-DSC Hot-Stage System with Imaging Capabilities for Obtaining Thermal Properties of Micro-Quantities of Materials2024-02-13T15:27:11+00:00

Joint research collaboration with Chemical Microscopy, LLC featured in the “Improving Product Quality & Material Understanding” special issue of Pharmaceutical Research

WEST LAFAYETTE, Ind., Jan. 26, 2024 /PRNewswire-PRWeb/ -- Research for low-dose therapeutics is a growing trend as promising new highly potent therapeutic agents are developed. Compounds deemed "highly potent" in pharmaceutical pipelines today describe nearly half of all market approved products and half of the small molecules currently advancing in clinical studies. Therefore, understanding how Read more

Joint research collaboration with Chemical Microscopy, LLC featured in the “Improving Product Quality & Material Understanding” special issue of Pharmaceutical Research2024-01-26T14:30:50+00:00

Joint research collaboration between Merck, Purdue University, Argonne National Laboratory, and Improved Pharma

WEST LAFAYETTE, Ind., Nov. 9, 2023 /PRNewswire-PRWeb/ -- Amorphous drugs have become a critical component in modern medicine and in drug development pipelines. Understanding the structural basis of phase stability of these materials is critical in the design of drug products, and yet remains a challenge due to the limited availability of high-resolution analytical tools. In Read more

Joint research collaboration between Merck, Purdue University, Argonne National Laboratory, and Improved Pharma2024-05-30T16:00:34+00:00

Improved Pharma at AAPS 2023 PHARMSCI 360 with booth #3323, two posters, and an invited talk as a Speaker Spotlight

WEST LAFAYETTE, Ind., Oct. 10, 2023 /PRNewswire-PRWeb  Starting Monday, October 23rd at 12:30 PM, Dr. Susan-Bogdanowich-Knipp, President of Ravine Pharmaceuticals and Consultant with Improved Pharma, will present "Physical Evaluation of Late Appearing Polymorph of Ritonavir Form III." The physico-chemical characterization of the recently-prepared Ritonavir, Form III will be described. The full poster can be accessed Read more

Improved Pharma at AAPS 2023 PHARMSCI 360 with booth #3323, two posters, and an invited talk as a Speaker Spotlight2023-10-10T12:23:19+00:00

Improved Pharma Enhances Solid-State Analytical Capabilities with Cutting-Edge Empyrean X-ray Diffractometer

WEST LAFAYETTE, Ind., Oct. 2, 2023 /PRNewswire-PRWeb/  Improved Pharma is pleased to announce it has recently purchased a Malvern PANalytical Empyrean Multi-Purpose X-ray Diffractometer. This instrument is housed in their new laboratory expansion area and supports their growing research and development business. CSO Stephen Byrn explains "X-ray Powder Diffraction (XRPD) stands as the cornerstone of solid-state form analysis, Read more

Improved Pharma Enhances Solid-State Analytical Capabilities with Cutting-Edge Empyrean X-ray Diffractometer2023-10-04T19:59:49+00:00

Improved Pharma expands laboratory space by 50% to accommodate recent growth in our research and development programs

WEST LAFAYETTE, Ind., Sept. 14, 2023 /PRNewswire-PRWeb/ -- Improved Pharma is pleased to announce it has recently expanded into adjacent laboratory space in the Purdue Kurz Technology Center. This expansion is the second since first acquiring laboratory space in 2020. The lab was also expanded in 2021. Business has increased more than 800% since 2019, driving the lab expansion. Read more

Improved Pharma expands laboratory space by 50% to accommodate recent growth in our research and development programs2023-09-14T14:37:47+00:00

Improved Pharma and Varda Space Industries conducting pharmaceutical experiments in space

WEST LAFAYETTE, IND. (PRWEB) JUNE 14, 2023 On board the rocket launch for the Transporter-8 Mission sat Varda’s satellite “W-Series 1”. Within the capsule sits the drug ritonavir, created by scientists at Improved Pharma and housed in engineering designed and built by Varda to conduct controlled experiments in microgravity. A little over an hour after launch, the satellite was Read more

Improved Pharma and Varda Space Industries conducting pharmaceutical experiments in space2023-06-14T13:39:43+00:00

Ritonavir research selected as a top “Remarkable Accomplishment”

Improved Pharma is pleased to announce that their ritonavir research with Varda Space Industries that was published earlier this year has been selected by Organic Process Research & Development as one of the top “remarkable accomplishments from the scientific literature that are expected to be relevant and important with future practical applications”. A brief summary of the work, along with other highlighted Read more

Ritonavir research selected as a top “Remarkable Accomplishment”2023-05-18T14:12:45+00:00
Go to Top